Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsAnuh pharma

    Anuh Pharma

    Jump to

    • Anuh Pharma Standalone September 2025 Net Sales at Rs 185.88 crore, up 12.01% Y-o-Y

    • Anuh Pharma Standalone June 2025 Net Sales at Rs 186.48 crore, up 35.22% Y-o-Y

    • Anuh Pharma Standalone March 2025 Net Sales at Rs 198.14 crore, up 20.9% Y-o-Y

    • Anuh Pharma Standalone December 2024 Net Sales at Rs 159.51 crore, down 7.31% Y-o-Y

    • Anuh Pharma Standalone September 2024 Net Sales at Rs 165.95 crore, up 10.98% Y-o-Y

    • Anuh Pharma Standalone June 2024 Net Sales at Rs 137.91 crore, down 14.6% Y-o-Y

    • Anuh Pharma Standalone March 2024 Net Sales at Rs 163.89 crore, up 4.18% Y-o-Y

    • Anuh Pharma Standalone September 2023 Net Sales at Rs 149.53 crore, up 29.95% Y-o-Y

    • Anuh Pharma Standalone June 2023 Net Sales at Rs 161.48 crore, up 38.76% Y-o-Y

    • Anuh Pharma Standalone March 2023 Net Sales at Rs 157.31 crore, up 21.97% Y-o-Y

    • Anuh Pharma Standalone December 2022 Net Sales at Rs 138.73 crore, up 5.37% Y-o-Y

    • Anuh Pharma Standalone September 2022 Net Sales at Rs 115.07 crore, up 5.82% Y-o-Y

    • Anuh Pharma Standalone June 2022 Net Sales at Rs 116.38 crore, down 0.76% Y-o-Y

    • Anuh Pharma Standalone March 2022 Net Sales at Rs 128.97 crore, up 32.76% Y-o-Y

    • Anuh Pharma Standalone December 2021 Net Sales at Rs 131.66 crore, up 33.9% Y-o-Y

    • Anuh Pharma Standalone September 2021 Net Sales at Rs 108.74 crore, down 3.11% Y-o-Y

    • Anuh Pharma Standalone June 2021 Net Sales at Rs 117.27 crore, down 5.61% Y-o-Y

    • Anuh Pharma Standalone December 2020 Net Sales at Rs 98.33 crore, up 29.62% Y-o-Y

    • Anuh Pharma Standalone June 2020 Net Sales at Rs 124.25 crore, up 46.36% Y-o-Y

    • Anuh Pharma Standalone March 2020 Net Sales at Rs 72.05 crore, down 13.24% Y-o-Y

    • COVID-19: Which pharma companies can benefit from the export ban relaxation?

      While there is a partial relaxation in exports of Hydroxychloroquine, the potential first line of treatment for COVID patients, the main question is the ability to meet domestic needs

    • Anuh Pharma Standalone March 2019 Net Sales at Rs 83.05 crore, up 23.77% Y-o-Y

    • Anuh Pharma Standalone December 2018 Net Sales at Rs 70.00 crore, up 10.53% Y-o-Y

    • Anuh Pharma Standalone September 2018 Net Sales at Rs 87.37 crore, up 57.97% Y-o-Y

    • Anuh Pharma shares gain 20% on EU GMP certificate for 2 products

      Anuh Pharma shares rallied 20 percent intraday Friday after getting European Medicines good manufacturing practice certificate for 2 products.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347